---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-078587"
form_type: "8-K/A"
ticker: "AVBP"
cik: "0001868279"
company_name: "ArriVent BioPharma, Inc."
filed_at: "2024-07-09T23:59:59+00:00"
generated_at: "2026-05-31T22:39:47.680479+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# ArriVent BioPharma appoints Dr. Hohneker to two board committees

## Summary
- Dr. John Hohneker appointed to Nominating and Corporate Governance Committee, effective July 3, 2024.
- Also appointed to Compensation Committee of the Board, effective same date.
- Amendment corrects omission from original May 16, 2024 8-K reporting his director election.

## SEC filing metadata
- accession: 0001104659-24-078587
- form_type: 8-K/A
- ticker: AVBP
- cik: 0001868279
- company_name: ArriVent BioPharma, Inc.
- filed_at: 2024-07-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1868279/000110465924078587/0001104659-24-078587-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1868279/000110465924078587/tm2419108d2_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-078587
- JSON: https://secwatch.observer/filing/0001104659-24-078587.json
- Plain text: https://secwatch.observer/filing/0001104659-24-078587.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.